The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler

Buttini, 2016, Effect of flow rate on in vitro aerodynamic performance of NEXThaler® in comparison with Diskus® and Turbohaler® dry powder inhalers, J. Aerosol Med. Pulm. Drug Deliv., 29, 167, 10.1089/jamp.2015.1220 Buttini, 2016, Multivariate analysis of effects of asthmatic patient respiratory profiles on the in vitro performance of a reservoir multidose and a capsule-based dry powder inhaler, Pharm. Res., 33, 701, 10.1007/s11095-015-1820-1 Buttini, 2021, Understanding the importance of capsules in dry powder inhalers, Pharmaceutics, 10.3390/pharmaceutics13111936 Chrystyn, 2017, Device errors in asthma and COPD: systematic literature review and meta-analysis, NPJ Prim. Care Respir. Med., 27, 10.1038/s41533-017-0016-z Chung, 2009, Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future, Eur. J. Clin. Pharmacol., 10.1007/s00228-009-0682-z Corradi, 2014, NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma, Expert Opin Drug Deliv, 11, 1497, 10.1517/17425247.2014.928282 Fink, J.B., Rubin, B.K., Fink RRT FAARC, J.B., Rubin MEngr MBA FAARC, B.K., 2005. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 50, 1360–1365. Grant, 2015, The Ellipta® dry powder inhaler: design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers, J. Aerosol Med. Pulm. Drug Deliv., 28, 474, 10.1089/jamp.2015.1223 Harb, 2020, First-time handling of different inhalers by chronic obstructive lung disease patients, Exp. Lung Res., 46, 258, 10.1080/01902148.2020.1789903 Jones, 2018, The Ellipta® in asthma and chronic obstructive pulmonary disease: device  characteristics and patient acceptability, Ther. Deliv., 9, 169, 10.4155/tde-2017-0103 Lai, C.C., Chen, C.H., Chen, K.H., Wang, C.Y., Huang, T.M., Wang, Y.H., Wang, H.C., 2022. The impact of 52-week single inhaler device triple therapy versus dual therapy on the mortality of COPD patients: a systematic review and meta-analysis of randomized controlled trials. Life 12,173. doi:10.3390/life12020173. Lavorini, 2019, 100 years of drug delivery to the lungs, Handb. Exp. Pharmacol., 260, 143, 10.1007/164_2019_335 Lavorini, 2008, Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD, Respir. Med., 102, 593, 10.1016/j.rmed.2007.11.003 Makhinova, 2020, Checking inhaler technique in the community pharmacy: predictors of critical errors, Pharmacy, 8, 6, 10.3390/pharmacy8010006 Melani, 2011, Inhaler mishandling remains common in real life and is associated with reduced disease control, Respir. Med., 105, 930, 10.1016/j.rmed.2011.01.005 Saeed, 2019, Effect of human error, inhalation flow, and inhalation volume on dose delivery from Ellipta® dry-powder inhaler, J. Pharm. Innov., 14, 239, 10.1007/s12247-018-9352-y Shur, 2016, From single excipients to dual excipient platforms in dry powder inhaler products, Int. J. Pharm., 514, 374, 10.1016/j.ijpharm.2016.05.057 Tashkin, 2021, The role of ICS/LABA fixed-dose combinations in the treatment of asthma and COPD: bioequivalence of a generic fluticasone propionate-salmeterol device, Pulm Med., 2021, 10.1155/2021/8881895 Usmani, 2018, Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes, Respir. Res. 19, 10, 10.1186/s12931-017-0710-y van der Palen, 1999, Multiple inhalers confuse asthma patients, Eur. Respir. J., 14, 1034, 10.1183/09031936.99.14510349 Virchow, 2018, Lung deposition of the dry powder fixed combination beclometasone dipropionate plus formoterol fumarate using NEXThaler® device in healthy subjects, asthmatic patients, and COPD patients, J. Aerosol Med. Pulm. Drug Deliv., 31, 269, 10.1089/jamp.2016.1359 Voshaar, 2014, Comparing usability of NEXThaler® with other inhaled corticosteroid/long-acting  β2-agonist fixed combination dry powder inhalers in asthma patients, J. Aerosol Med. Pulm. Drug Deliv., 27, 363, 10.1089/jamp.2013.1086 Watz, 2021, Targeting the small airways with inhaled corticosteroid/long-acting beta agonist dry powder inhalers: a functional respiratory imaging study, J. Aerosol Med. Pulm. Drug Deliv., 34, 280, 10.1089/jamp.2020.1618 Will, 2019, Understanding dry powder inhalers: key technical and patient preference attributes, Adv. Ther., 36 Yeung, 2018, Dosing challenges in respiratory therapies, Int. J. Pharm., 548, 659, 10.1016/j.ijpharm.2018.07.007